Delivery Order SPE2DB20D3505-SPE2DB25FYCKD
- Not listed
- The Defense Logistics Agency awarded a $3,992.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ivabradine HCl 5 mg tablets (60-count). This non-set-aside contract is scheduled for completion by August 1, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ivabradine HCL 5 mg tablets (60-count units) with a ceiling value of $19,104.45. This is a firm fixed-price, non-set-aside delivery order that will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ivabradine HCL 5 mg tablets (60-count units) with a ceiling value of $3,598.88. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Ivabradine HCl 5mg tablets. The contract is a $1,718.01 firm fixed price delivery order, with an ultimate completion date of August 22, 2024. The award date was August 21, 2024, and there was no set-aside designation used. This order is likely part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The $5,655.07 firm fixed-price delivery order contract is for the supply of 4565405881 - Ivabradine HCL 5 mg Tablets in 60-count packages. The contract has an ultimate completion date of August 12, 2024 and was awarded on August 9, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order valued at $9,188.29 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a quantity of 60 units. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,002.50 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a 60-count quantity. The contract, awarded September 10, 2025, with completion targeted for September 11, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,643.36 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a quantity of 60 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on September 6, 2025, and scheduled for completion by September 8, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Irbesartan 150 mg tablets in quantities of 90 units, with a contract ceiling value of $2,260.39. This firm fixed-price delivery order, which is set to be completed by August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a $5,160.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Irbesartan 150 mg on August 11, 2025, with completion due by August 12, 2025. This contract was competitively awarded with no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCKDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.01 to AmerisourceBergen Drug Corp for the supply of Ivabradine HCl 5 mg tablets (60-count package) on September 11, 2025, with an ultimate completion date of September 12, 2025. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA contract vehicle. Ivabradine is a cardiovascular medication indicated for heart failure treatment, reflecting the company's role in supplying essential pharmaceutical products across multiple therapeutic domains to support military and federal healthcare programs. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the delivery of brand-name and generic medications, vaccines, specialty drugs, and related medical supplies to military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/11/25 |